Journal of Movement Disorders

Original Article

Effectiveness of live-streaming tele-exercise intervention in patients with Parkinson’s disease: A pilot study: Jongmok Ha, Jung Hyun Park, Jun Seok Lee, Hye Young Kim, Ji One Song, Jiwon Yoo, Jong Hyeon Ahn, Jinyoung Youn, Jin Whan Cho; Received November 29, 2023 Accepted February 29, 2024 Published online February 29, 2024; DOI: https://doi.org/10.14802/jmd.23251 [Accepted]

487 View
40 Download

Abstract PDF: Introduction
Exercise can improve both motor and non-motor symptoms in people with Parkinson’s disease (PwP), but there is an unmet need of accessible and sustainable exercise options. This study aimed to evaluate the effect, feasibility, and safety of a regularly performed live-streaming tele-exercise intervention for PwP.
Methods
A live-streaming exercise intervention was implemented twice a week for 12 weeks in PwP. We measured the motor and nonmotor scales in these patients before and after the intervention. Changes in clinical scores from baseline to post-intervention were analyzed using a paired t-test. Factors associated with improvements in clinical scales and compliance were analyzed using Pearson’s correlation analysis.
Results
56 participants were enrolled in the study. There were significant improvements in HADS-A (p = 0.007), HADS-D (p < 0.001), UPDRS part III (p < 0.001), UPDRS total (p = 0.015), H&Y stage (p = 0.027), and PFS-16 (p = 0.026) scores following intervention. Motor improvements were associated with improvements in mood symptoms and fatigue. Higher motor impairment at baseline was associated with a higher compliance rate and better composite motor and non-motor outcomes (ΔUPDRS total score) post-intervention. Overall, the 12-week tele-exercise program was feasible and safe for PwP. No adverse event was reported. Overall adherence was 60.0% in our cohort, and 83.4% were able to participate in more than half of the exercise routines.
Conclusion
The live-streaming tele-exercise intervention is a safe, feasible, and effective non-pharmacological treatment option that can alleviate fatigue and improve mood and motor symptoms in PwP.

Review Article

Gastrointestinal Dysfunction in Parkinson’s Disease: Neuro-Gastroenterology Perspectives on a Multifaceted Problem: Ai Huey Tan, Kee Huat Chuah, Yuan Ye Beh, Jie Ping Schee, Sanjiv Mahadeva, Shen-Yang Lim; J Mov Disord. 2023;16(2):138-151. Published online May 24, 2023; DOI: https://doi.org/10.14802/jmd.22220

2,494 View
179 Download

Abstract PDF: Patients with Parkinson’s disease (PD) face a multitude of gastrointestinal (GI) symptoms, including nausea, bloating, reduced bowel movements, and difficulties with defecation. These symptoms are common and may accumulate during the course of PD but are often under-recognized and challenging to manage. Objective testing can be burdensome to patients and does not correlate well with symptoms. Effective treatment options are limited. Evidence is often based on studies in the general population, and specific evidence in PD is scarce. Upper GI dysfunction may also interfere with the pharmacological treatment of PD motor symptoms, which poses significant management challenges. Several new less invasive assessment tools and novel treatment options have emerged in recent years. The current review provides an overview and a practical approach to recognizing and diagnosing common upper and lower GI problems in PD, e.g., dyspepsia, gastroparesis, small bowel dysfunction, chronic constipation, and defecatory dysfunction. Management aspects are discussed based on the latest evidence from the PD and general populations, with insights for future research pertaining to GI dysfunction in PD.

Original Article

Asymptomatic Hearing Impairment Frequently Occurs in Early-Onset Parkinson’s Disease: Kuldeep Shetty, Syam Krishnan, Jissa Vinoda Thulaseedharan, Manju Mohan, Asha Kishore; J Mov Disord. 2019;12(2):84-90. Published online April 5, 2019; DOI: https://doi.org/10.14802/jmd.18048

13,361 View
271 Download
19 Web of Science
14 Crossref

Abstract PDF

Objective
Recent reports of hearing impairment in Parkinson’s disease (PD) have suggested that auditory dysfunction could be a non-motor manifestation of PD. These reports were based on observations of elderly patients for whom presbycusis may, to some extent, have contributed to hearing dysfunction. Therefore, we aimed to explore the auditory functions in younger patients with PD. Methods We conducted a case-control study in a relatively younger (< 55 years of age at study time) population of PD patients and healthy volunteers to test whether auditory dysfunction is a significant non-motor dysfunction in PD. Pure tone audiometry (PTA) and brainstem evoked response audiometry (BERA) were performed in all participants. Results None of the patients or controls reported hearing deficits. Fifty-one patients with PD and 50 healthy volunteers who were age- and gender-matched to the patients participated. PTA-detected hearing impairment was found in 64.7% of patients and 28% of controls (p < 0.001) for both low-mid and/or high frequencies. Hearing impairment was more frequent in the younger subgroups of patients than age-matched controls, while the frequency of hearing impairment was similar in older groups of subjects. BERA was not different between patients and controls. Conclusion Asymptomatic auditory dysfunction is a common non-motor manifestation of early-onset PD and more frequent in younger patients, indicating that it may be independent of aging. The mechanism underlying this dysfunction appears to be peripheral, although a central dysfunction cannot be ruled out based on the findings of this study.

Citations

Citations to this article as recorded by

Hearing dysfunction heralds an increase in non-motor burden and a worse quality of life in Parkinson’s disease: new insights from non-motor spectrum
Elena Garasto, Alessandro Stefani, Mariangela Pierantozzi, Matteo Conti, Arturo Moleti, Renata Sisto, Andrea Viziano, Claudio Liguori, Tommaso Schirinzi, Nicola Biagio Mercuri, Rocco Cerroni
Neurological Sciences.2024;[Epub] CrossRef
Peripheral hearing in Parkinson’s disease: a systematic review
Mariana S. Leme, Seisse G. G. Sanches, Renata M. M. Carvallo
International Journal of Audiology.2023; 62(9): 805. CrossRef
(Zu-)Hören mit alterndem Gehirn – eine kognitive Herausforderung
Wilma Großmann
Laryngo-Rhino-Otologie.2023; 102(S 01): S12. CrossRef
Is Hearing Loss a Risk Factor for Idiopathic Parkinson’s Disease? An English Longitudinal Study of Ageing Analysis
Megan Rose Readman, Fang Wan, Ian Fairman, Sally A. Linkenauger, Trevor J. Crawford, Christopher J. Plack
Brain Sciences.2023; 13(8): 1196. CrossRef
Hearing Loss and Disorders: The Repercussions of Climate Change
Sue Sherratt
American Journal of Audiology.2023; 32(4): 793. CrossRef
Association between hearing sensitivity and dopamine transporter availability in Parkinson’s disease
Elena Garasto, Alessandro Stefani, Mariangela Pierantozzi, Rocco Cerroni, Matteo Conti, Simone Maranesi, Nicola B Mercuri, Agostino Chiaravalloti, Orazio Schillaci, Andrea Viziano, Arturo Moleti, Renata Sisto
Brain Communications.2023;[Epub] CrossRef
Identifying Parkinson Risk Markers in Primary Care—Old Associations and New Insights
Bhavana Patel, Shannon Chiu, Melissa J. Armstrong
JAMA Neurology.2022; 79(4): 331. CrossRef
Assessment of Risk Factors and Early Presentations of Parkinson Disease in Primary Care in a Diverse UK Population
Cristina Simonet, Jonathan Bestwick, Mark Jitlal, Sheena Waters, Aaron Ben-Joseph, Charles R. Marshall, Ruth Dobson, Soha Marrium, John Robson, Benjamin M. Jacobs, Daniel Belete, Andrew J. Lees, Gavin Giovannoni, Jack Cuzick, Anette Schrag, Alastair J. No
JAMA Neurology.2022; 79(4): 359. CrossRef
Auditory impairment in H‐ABC tubulinopathy
Alejandra Lopez‐Juarez, Arturo Gonzalez‐Vega, Anke Kleinert‐Altamirano, Valeria Piazza, Angeles Garduno‐Robles, Milvia Alata, Carlos Villaseñor‐Mora, Jose R. Eguibar, Carmen Cortes, Luis Carlos Padierna, Victor H. Hernandez
Journal of Comparative Neurology.2021; 529(5): 957. CrossRef
The Effect of Parkinson's Disease on Otoacoustic Emissions and Efferent Suppression of Transient Evoked Otoacoustic Emissions
Evelien De Groote, Annelies Bockstael, Dick Botteldooren, Patrick Santens, Miet De Letter
Journal of Speech, Language, and Hearing Research.2021; 64(4): 1354. CrossRef
Hearing Loss in Neurological Disorders
Siyu Li, Cheng Cheng, Ling Lu, Xiaofeng Ma, Xiaoli Zhang, Ao Li, Jie Chen, Xiaoyun Qian, Xia Gao
Frontiers in Cell and Developmental Biology.2021;[Epub] CrossRef
Age-Related Changes in the Cochlea and Vestibule: Shared Patterns and Processes
Vasiliki Paplou, Nick M. A. Schubert, Sonja J. Pyott
Frontiers in Neuroscience.2021;[Epub] CrossRef
Auditory Dysfunction in Parkinson's Disease
Zahra Jafari, Bryan E. Kolb, Majid H. Mohajerani
Movement Disorders.2020; 35(4): 537. CrossRef
Future Perspectives on the Relevance of Auditory Markers in Prodromal Parkinson's Disease
Evelien De Groote, Kim De Keyser, Patrick Santens, Durk Talsma, Annelies Bockstael, Dick Botteldooren, Miet De Letter
Frontiers in Neurology.2020;[Epub] CrossRef

Review Article

Many Faces of Parkinson’s Disease: Non-Motor Symptoms of Parkinson’s Disease: Hye Mi Lee, Seong-Beom Koh; J Mov Disord. 2015;8(2):92-97. Published online May 31, 2015; DOI: https://doi.org/10.14802/jmd.15003

22,228 View
542 Download
97 Web of Science
93 Crossref

Abstract PDF

Parkinson’s disease (PD) is a multi-systemic disorder that is characterized by a combination of motor and non-motor symptoms (NMS). The dopaminergic neurodegeneration of PD is involved in the genesis of NMS, but other conditions and side effects of levodopa are also associated with NMS. NMS can develop at all stage of PD and rapid eyeball movement sleep behavior disorder (RBD), constipation, depression, and olfactory dysfunction are considered prodromal signs of PD. Many NMS related with motor deficits and cognitive dysfunction. Some NMS including olfactory dysfunction, RBD and abnormal stereopsis are associated with presence of other NMS of PD. In addition, several NMS can be helpful to differentiate between idiopathic PD and other parkinsonian disorders. Early recognition and management of NMS in PD patients is important for preserving quality of life.

Citations

Citations to this article as recorded by

Challenges in Managing Nonmotor Symptoms of Parkinson's Disease in Low‐Resourced Settings with Unavailability of Newer Drugs
Zakiyah Aldaajani, Hanan Khalil
Movement Disorders Clinical Practice.2024; 11(2): 123. CrossRef
Is there any correlation between alpha-synuclein levels in tears and retinal layer thickness in Parkinson's disease?
Azyadeh Camacho-Ordonez, Amin Cervantes-Arriaga, Mayela Rodríguez-Violante, Ana Jimena Hernandez-Medrano, Selma Alin Somilleda-Ventura, Hector J. Pérez-Cano, Ángel Nava-Castañeda, Oscar Guerrero-Berger
European Journal of Ophthalmology.2024; 34(1): 252. CrossRef
Robotic technology for Parkinson's disease: Needs, attitudes and concerns of individuals with Parkinson's disease and their family members. A focus group study
Azriel Kaplan, Shirel Barkan-Slater, Yair Zlotnik, Shelly Levy-Tzedek
International Journal of Human-Computer Studies.2024; 181: 103148. CrossRef
Associations of dual-task walking costs with cognition in Parkinson’s disease
Danial Kazemi, Amir Shayan Chadeganipour, Mina Dehghani, Fatemeh Ghorbali
Gait & Posture.2024; 110: 48. CrossRef
Neuroprotective effect of anethole against rotenone induced non-motor deficits and oxidative stress in rat model of Parkinson’s disease
Sadegh Moradi Vastegani, Seyed Esmaeil Khoshnam, Esrafil Mansouri, Somayeh Hajipour, Samireh Ghafouri, Nima Bakhtiari, Alireza Sarkaki, Yaghoob Farbood
Behavioural Brain Research.2023; 437: 114100. CrossRef
The effects of synbiotic supplementation on oxidative stress markers, mental status, and quality of life in patients with Parkinson’s disease: A double-blind, placebo-controlled, randomized controlled trial
Sanaz Mehrabani, Fariborz Khorvash, Zahra Heidari, Maryam Tajabadi-Ebrahimi, Reza Amani
Journal of Functional Foods.2023; 100: 105397. CrossRef
Role of Ceramides and Sphingolipids in Parkinson's Disease
Melissa Vos, Christine Klein, Andrew A Hicks
Journal of Molecular Biology.2023; 435(12): 168000. CrossRef
Efficacy of herbal medicine treatment based on syndrome differentiation for Parkinson’s disease: A systematic review and meta-analysis of randomized placebo-controlled clinical trials
Purumea Jun, HuiYan Zhao, In Chul Jung, Ojin Kwon, Chang-Hyun Han, Jiyoon Won, Jung-Hee Jang
Frontiers in Pharmacology.2023;[Epub] CrossRef
A meta-analysis of exercise intervention and the effect on Parkinson’s Disease symptoms
Syed Omar Ahmad, Jason Longhurst, Dana Stiles, Lana Downard, Stephanie Martin
Neuroscience Letters.2023; 801: 137162. CrossRef
Controlling the Impact of Helicobacter pylori-Related Hyperhomocysteinemia on Neurodegeneration
Jannis Kountouras, Michael Doulberis, Apostolis Papaefthymiou, Stergios A. Polyzos, Christos Zavos, Evangelos Kazakos, Stergios Arapoglou, Foteini Kyrailidi, Maria C. Mouratidou, Marina Boziki, Elisabeth Vardaka
Medicina.2023; 59(3): 504. CrossRef
Case management interventions in chronic disease reduce anxiety and depressive symptoms: A systematic review and meta-analysis
Angelika D. Geerlings, Jules M. Janssen Daalen, Jan H. L. Ypinga, Bastiaan R. Bloem, Marjan J. Meinders, Marten Munneke, Sirwan K. L. Darweesh, Vincenzo De Luca
PLOS ONE.2023; 18(4): e0282590. CrossRef
Bio-synthesized selenium nanoparticles ameliorate Brain oxidative stress in Parkinson disease rat models
Sanaz Salaramoli, Hamed Amiri, Hamid Reza Joshaghani, Mahmoud Hosseini, Seyed Isaac Hashemy
Metabolic Brain Disease.2023; 38(6): 2055. CrossRef
Therapeutic Approaches to Non-Motor Symptoms of Parkinson's Disease: A Current Update on Preclinical Evidence
Poornima D.E. Weerasinghe-Mudiyanselage, Sohi Kang, Joong-Sun Kim, Changjong Moon
Current Neuropharmacology.2023; 21(3): 560. CrossRef
Psychosis in Parkinson’s Disease and Current Management Trends- an Updated Review of Literature
Dutta Rajib
Journal of Neuroscience and Neurological Disorders.2023; 7(2): 027. CrossRef
The Molecular Mechanisms of the Relationship between Insulin Resistance and Parkinson’s Disease Pathogenesis
Viviana A. Ruiz-Pozo, Rafael Tamayo-Trujillo, Santiago Cadena-Ullauri, Evelyn Frias-Toral, Patricia Guevara-Ramírez, Elius Paz-Cruz, Sebastián Chapela, Martha Montalván, Tania Morales-López, Daniel Simancas-Racines, Ana Karina Zambrano
Nutrients.2023; 15(16): 3585. CrossRef
Enhancing Parkinson's disease severity assessment through voice-based wavelet scattering, optimized model selection, and weighted majority voting
Farhad Abedinzadeh Torghabeh, Seyyed Abed Hosseini, Elham Ahmadi Moghadam
Medicine in Novel Technology and Devices.2023; 20: 100266. CrossRef
A look back at the prodromal findings in Parkinson’s disease
Seyed-Amirabbas Ahadiat, Zeinab Hosseinian
Bulletin of the National Research Centre.2023;[Epub] CrossRef
Parkinson’s Disease Non-Motor Subtypes Classification in a Group of Slovenian Patients: Actuarial vs. Data-Driven Approach
Timotej Petrijan, Jan Zmazek, Marija Menih
Journal of Clinical Medicine.2023; 12(23): 7434. CrossRef
Unveiling the Hidden Challenges: Non-Motor Disorders in Parkinson’s Disease
Francisco Nieto-Escamez, Esteban Obrero-Gaitán, Héctor García-López, Irene Cortés-Pérez
Brain Sciences.2023; 13(12): 1710. CrossRef
REM sleep behavioral disorder may be an independent risk factor for orthostatic hypotension in Parkinson’s disease
Kangfu Yin, Chuanbin Zhou, Yongyun Zhu, Weifang Yin, Lei Yin, Bin Liu, Hui Ren, Zhong Xu, Xinglong Yang
Aging Clinical and Experimental Research.2022; 34(1): 159. CrossRef
Gender Differences and Impact of Autonomic Disturbance on Fatigue and Quality of Life in Parkinson's Disease
NahushR Bansal, BirinderS Paul, Gunchan Paul, Gagandeep Singh
Neurology India.2022; 70(1): 203. CrossRef
Exploring Unmet Information Needs of People with Parkinson’s Disease and Their Families: Focusing on Information Sharing in an Online Patient Community
Hyeon Sik Chu, Hye Young Jang
International Journal of Environmental Research and Public Health.2022; 19(5): 2521. CrossRef
Gut microbiota and inflammation in Parkinson’s disease: Pathogenetic and therapeutic insights
Tong Guo, Li Chen
European Journal of Inflammation.2022; 20: 1721727X2210837. CrossRef
Diffusion Tensor Imaging Reveals Deep Brain Structure Changes in Early Parkinson’s Disease Patients with Various Sleep Disorders
Yanyan Jiang, Hedi An, Qian Xi, Weiting Yang, Hongrong Xie, Yang Li, Dongya Huang
Brain Sciences.2022; 12(4): 463. CrossRef
Clinical Aspects of the Differential Diagnosis of Parkinson’s Disease and Parkinsonism
Hae-Won Shin, Sang-Wook Hong, Young Chul Youn
Journal of Clinical Neurology.2022; 18(3): 259. CrossRef
Effect of mobile health intervention for self-management on self-efficacy, motor and non-motor symptoms, self-management, and quality of life in people with Parkinson's disease: Randomized controlled trial
Yusun Park, Sung Reul Kim, Hui Young So, Sungyang Jo, Seung Hyun Lee, Yun su Hwang, Mi Sun Kim, Sun Ju Chung
Geriatric Nursing.2022; 46: 90. CrossRef
Ghrelin mediated regulation of neurosynaptic transmitters in depressive disorders
Milind V. Masule, Sumit Rathod, Yogeeta Agrawal, Chandragouda R. Patil, Kartik T. Nakhate, Shreesh Ojha, Sameer N. Goyal, Umesh B. Mahajan
Current Research in Pharmacology and Drug Discovery.2022; 3: 100113. CrossRef
Psychosis in Parkinson’s Disease: A Lesson from Genetics
Efthalia Angelopoulou, Anastasia Bougea, Sokratis G. Papageorgiou, Chiara Villa
Genes.2022; 13(6): 1099. CrossRef
Non-motor manifestation of Parkinson's disease: a cross-sectional study in a teaching hospital in Jordan
Said Salah Dahbour, Mohammad J. Al Murr, Liyan H. Oweis, Nada T. Al Antary, Maram Mohsen, Safa Al Fegi
The Egyptian Journal of Neurology, Psychiatry and Neurosurgery.2022;[Epub] CrossRef
Neuroprotective effects of probiotics bacteria on animal model of Parkinson’s disease induced by 6-hydroxydopamine: A behavioral, biochemical, and histological study
Esmail Alipour Nosrani, Omid Reza Tamtaji, Zahra Alibolandi, Parichehr Sarkar, Mohsen Ghazanfari, Abolfazl Azami Tameh, Mohsen Taghizadeh, Zarrin Banikazemi, Razie Hadavi, Mojtaba Naderi Taheri
Journal of Immunoassay and Immunochemistry.2021; 42(2): 106. CrossRef
SURINPARK: Safinamide for Urinary Symptoms in Parkinson’s Disease
Ana Gómez-López, Arantxa Sánchez-Sánchez, Elena Natera-Villalba, Victoria Ros-Castelló, Álvaro Beltrán-Corbellini, Samira Fanjul-Arbós, Isabel Pareés Moreno, José Luis López-Sendon Moreno, Juan Carlos Martínez Castrillo, Araceli Alonso-Canovas
Brain Sciences.2021; 11(1): 57. CrossRef
People with Parkinson’s Disease: What Symptoms Do They Most Want to Improve and How Does This Change with Disease Duration?
Rebecca J. Port, Martin Rumsby, Graham Brown, Ian F. Harrison, Anneesa Amjad, Claire J. Bale
Journal of Parkinson's Disease.2021; 11(2): 715. CrossRef
Rho‐kinase inhibition by fasudil modulates pre‐synaptic vesicle dynamics
Kim Ann Saal, Carmina Warth Pérez Arias, Anna‐Elisa Roser, Jan Christoph Koch, Mathias Bähr, Silvio O. Rizzoli, Paul Lingor
Journal of Neurochemistry.2021; 157(4): 1052. CrossRef
A Comprehensive Phenotype of Non-motor Impairments and Distribution of Alpha-Synuclein Deposition in Parkinsonism-Induced Mice by a Combination Injection of MPTP and Probenecid
Na-Ra Han, Yu-Kang Kim, Sora Ahn, Tae-Yeon Hwang, Hyejung Lee, Hi-Joon Park
Frontiers in Aging Neuroscience.2021;[Epub] CrossRef
Association of Parkinson’s Disease With Microbes and Microbiological Therapy
Zhao-Ji Chen, Cheng-Yu Liang, Li-Qing Yang, Si-Min Ren, Yan-Min Xia, Lei Cui, Xiao-Fang Li, Bu-Lang Gao
Frontiers in Cellular and Infection Microbiology.2021;[Epub] CrossRef
Plasma Lipopolysaccharide-Binding Protein Reflects Risk and Progression of Parkinson’s Disease
Szu-Ju Chen, Yu-Chiao Chi, Chang-Han Ho, Wei-Shiung Yang, Chin-Hsien Lin
Journal of Parkinson's Disease.2021; 11(3): 1129. CrossRef
The Importance of Drosophila melanogaster Research to UnCover Cellular Pathways Underlying Parkinson’s Disease
Melissa Vos, Christine Klein
Cells.2021; 10(3): 579. CrossRef
Docosahexaenoic and Arachidonic Acids as Neuroprotective Nutrients throughout the Life Cycle
Verónica Sambra, Francisca Echeverria, Alfonso Valenzuela, Raphaël Chouinard-Watkins, Rodrigo Valenzuela
Nutrients.2021; 13(3): 986. CrossRef
What substance P might tell us about the prognosis and mechanism of Parkinson's disease?
Paola Tirassa, Tommaso Schirinzi, Marcello Raspa, Massimo Ralli, Antonio Greco, Antonella Polimeni, Roberta Possenti, Nicola Biagio Mercuri, Cinzia Severini
Neuroscience & Biobehavioral Reviews.2021; 131: 899. CrossRef
Baicalein alleviates depression-like behavior in rotenone- induced Parkinson's disease model in mice through activating the BDNF/TrkB/CREB pathway
Xiaoyue Zhao, Dewen Kong, Qimeng Zhou, Guangyi Wei, Junke Song, Yu Liang, Guanhua Du
Biomedicine & Pharmacotherapy.2021; 140: 111556. CrossRef
Apathy and actions- another consideration when theorizing about embodied nature of language in Parkinson's disease
Logan Wolff, Jared F. Benge, Samia Ortiz-Hernandez, Samantha Beevers, Alexandra Armitage, Jungjun Park, Daniel L. Drane
Journal of Communication Disorders.2021; 93: 106144. CrossRef
Association analysis and polygenic risk score evaluation of 38 GWAS-identified Loci in a Chinese population with Parkinson’s disease
Ran Zheng, Song Qiao, Ying Chen, Chongyao Jin, Yi Fang, Zhihao Lin, Naijia Xue, Yiqun Yan, Luyan Gu, Ting Gao, Jun Tian, Yaping Yan, Xinzhen Yin, Jiali Pu, Baorong Zhang
Neuroscience Letters.2021; 762: 136150. CrossRef
Non-motor impairments affect walking kinematics in Parkinson disease patients: A cross-sectional study
Sara Liguori, Antimo Moretti, Angela Palomba, Marco Paoletta, Francesca Gimigliano, Rosa De Micco, Mattia Siciliano, Alessandro Tessitore, Giovanni Iolascon
NeuroRehabilitation.2021; 49(3): 481. CrossRef
The role of gut dysbiosis in Parkinson’s disease: mechanistic insights and therapeutic options
Qing Wang, Yuqi Luo, K Ray Chaudhuri, Richard Reynolds, Eng-King Tan, Sven Pettersson
Brain.2021; 144(9): 2571. CrossRef
Clinical features contributing to the sit-to-stand transfer in people with Parkinson’s disease: a systematic review
Charmaine Pearl Da Cunha, Pratiksha Tilak Rao, Suruliraj Karthikbabu
The Egyptian Journal of Neurology, Psychiatry and Neurosurgery.2021;[Epub] CrossRef
Integration of Aluminium Interdigitated Electrodes with Zinc Oxide as Nanocomposite for Selectively Detect Alpha-Synuclein for Parkinson’s Disease Diagnosis
Hussaini Adam, Subash C. B Gopinath, Uda Hashim
Journal of Physics: Conference Series.2021; 2129(1): 012094. CrossRef
Effects of depression and exercise on health-related quality of life in patients with Parkinson's disease
George W Koutsouras, Kimberly Levine, Nathalie Duroseau, Christina Ciraco, Vivian Chan, Kathleen Pergament, Thomas Chan, Jayme D Mancini, Adena N Leder, Bhuma Krishnamachari
Chronic Illness.2020; 16(3): 190. CrossRef
Glial Cell Line–Derived Neurotrophic Factor Receptor Rearranged During Transfection Agonist Supports Dopamine Neurons In Vitro and Enhances Dopamine Release In Vivo
Arun Kumar Mahato, Jaakko Kopra, Juho‐Matti Renko, Tanel Visnapuu, Ilari Korhonen, Nita Pulkkinen, Maxim M. Bespalov, Andrii Domanskyi, Eric Ronken, T. Petteri Piepponen, Merja H. Voutilainen, Raimo K. Tuominen, Mati Karelson, Yulia A. Sidorova, Mart Saar
Movement Disorders.2020; 35(2): 245. CrossRef
Early transcranial direct current stimulation treatment exerts neuroprotective effects on 6-OHDA-induced Parkinsonism in rats
Xiao-Jun Feng, Yu-Ting Huang, Ying-Zu Huang, Chi-Wei Kuo, Chih-Wei Peng, Alexander Rotenberg, Chi-Hung Juan, Yu-Cheng Pei, Yuan-Hao Chen, Kai-Yun Chen, Yung-Hsiao Chiang, Hui-Hua Liu, Jian-Xian Wu, Tsung-Hsun Hsieh
Brain Stimulation.2020; 13(3): 655. CrossRef
Dizziness in patients with early stages of Parkinson's disease: Prevalence, clinical characteristics and implications
Kyum‐Yil Kwon, Suyeon Park, Mina Lee, Hyunjin Ju, Kayeong Im, Byung‐Euk Joo, Kyung Bok Lee, Hakjae Roh, Moo‐Young Ahn
Geriatrics & Gerontology International.2020; 20(5): 443. CrossRef
The Dysfunctional Autonomic Function and “Dysfunctional” Fatigue in Drug Naïve Parkinson’s Disease
Jong Hyeon Ahn, Minkyeong Kim, Jun Kyu Mun, Yoonsu Cho, Ji Sun Kim, Jinyoung Youn, Joong-Seok Kim, Jin Whan Cho
Journal of Parkinson's Disease.2020; 10(2): 605. CrossRef
Assessments of plasma acyl-ghrelin levels in Parkinson’s disease patients treated with deep brain stimulation
Wojciech Pietraszko, Agata Furgala, Agnieszka Gorecka-Mazur, Borys Kwinta, Jolanta Kaszuba-Zwoinska, Jaroslaw Polak, Urszula Fiszer, Krzysztof Gil, Anna Krygowska-Wajs
Peptides.2020; 128: 170299. CrossRef
Common and unique connectivity at the interface of motor, neuropsychiatric, and cognitive symptoms in Parkinson's disease: A commonality analysis
Stefan Lang, Zahinoor Ismail, Mekale Kibreab, Iris Kathol, Justyna Sarna, Oury Monchi
Human Brain Mapping.2020; 41(13): 3749. CrossRef
Systems Biology Approaches to Understand the Host–Microbiome Interactions in Neurodegenerative Diseases
Dorines Rosario, Jan Boren, Mathias Uhlen, Gordon Proctor, Dag Aarsland, Adil Mardinoglu, Saeed Shoaie
Frontiers in Neuroscience.2020;[Epub] CrossRef
Rpt2 proteasome subunit reduction causes Parkinson's disease like symptoms in Drosophila
Iván Fernández-Cruz, Iván Sánchez-Díaz, Verónica Narváez-Padilla, Enrique Reynaud
IBRO Reports.2020; 9: 65. CrossRef
Boxing to Improve Sleep Quality and Daytime Sleepiness in Individuals With Parkinson Disease
Macy Urrutia, Cynthia Ivy, Patricia S. Pohl, Linda Denney
Topics in Geriatric Rehabilitation.2020; 36(3): 170. CrossRef
Effects of the probiotic formulation SLAB51 in in vitro and in vivo Parkinson’s disease models
Vanessa Castelli, Michele d’Angelo, Francesca Lombardi, Margherita Alfonsetti, Andrea Antonosante, Mariano Catanesi, Elisabetta Benedetti, Paola Palumbo, Maria Grazia Cifone, Antonio Giordano, Giovambattista Desideri, Annamaria Cimini
Aging.2020; 12(5): 4641. CrossRef
Depressive symptoms are associated with worse cognitive prognosis in patients with newly diagnosed idiopathic Parkinson disease
Jeong Hoon Park, Seung Hwan Lee, Yeshin Kim, Sang‐Won Park, Gi Hwan Byeon, Jae‐Won Jang
Psychogeriatrics.2020; 20(6): 880. CrossRef
Lack of association between dopamine transporter loss and non-motor symptoms in patients with Parkinson’s disease: a detailed PET analysis of 12 striatal subregions
Soo Bin Park, Kyum-Yil Kwon, Jeong-Yoon Lee, Kayeong Im, Jun-Sang Sunwoo, Kyung Bok Lee, Hakjae Roh, Moo-Young Ahn, Suyeon Park, Soo-Jong Kim, Jungsu S. Oh, Jae Seung Kim
Neurological Sciences.2019; 40(2): 311. CrossRef
Cognitive Problems in Parkinson Disease: Perspectives and Priorities of Patients and Care Partners
Katrina L. Raein, Samia Ortiz-Hernández, Jared F. Benge
Cognitive and Behavioral Neurology.2019; 32(1): 16. CrossRef
Probiotics mixture increases butyrate, and subsequently rescues the nigral dopaminergic neurons from MPTP and rotenone-induced neurotoxicity
Sunil Srivastav, Sabita Neupane, Sunil Bhurtel, Nikita Katila, Sailesh Maharjan, Hyukjae Choi, Jin Tae Hong, Dong-Young Choi
The Journal of Nutritional Biochemistry.2019; 69: 73. CrossRef
Asymptomatic Hearing Impairment Frequently Occurs in Early-Onset Parkinson’s Disease
Kuldeep Shetty, Syam Krishnan, Jissa Vinoda Thulaseedharan, Manju Mohan, Asha Kishore
Journal of Movement Disorders.2019; 12(2): 84. CrossRef
Detecting Non-cognitive Features of Prodromal Neurodegenerative Diseases
Alon Seifan, Christine A. Ganzer, Krista Ryon, Michael Lin, Rahman Mahmudur, Henriquez Adolfo, Cindy Shih, Alan R. Jacobs, Molly Greenwald, Richard S. Isaacson
Current Aging Science.2019; 11(4): 242. CrossRef
Elevated Serum Homocysteine Levels Have Differential Gender-Specific Associations with Motor and Cognitive States in Parkinson’s Disease
Megan C. Bakeberg, Alexa Jefferson, Maddeson Riley, Michelle Byrnes, Soumya Ghosh, Frank L. Mastaglia, Malcom K. Horne, Sarah McGregor, Rick Stell, Jade Kenna, Sue Walters, Dana Hince, Ryan S. Anderton
Parkinson's Disease.2019; 2019: 1. CrossRef
α-Synuclein in Parkinson’s disease: causal or bystander?
Peter Riederer, Daniela Berg, Nicolas Casadei, Fubo Cheng, Joseph Classen, Christian Dresel, Wolfgang Jost, Rejko Krüger, Thomas Müller, Heinz Reichmann, Olaf Rieß, Alexander Storch, Sabrina Strobel, Thilo van Eimeren, Hans-Ullrich Völker, Jürgen Winkler,
Journal of Neural Transmission.2019; 126(7): 815. CrossRef
Selegiline Recovers Synaptic Plasticity in the Medial Prefrontal Cortex and Improves Corresponding Depression-Like Behavior in a Mouse Model of Parkinson’s Disease
Motoki Okano, Kazue Takahata, Junya Sugimoto, Shizuko Muraoka
Frontiers in Behavioral Neuroscience.2019;[Epub] CrossRef
Inner retinal thinning as a biomarker for cognitive impairment in de novo Parkinson’s disease
Mi Sun Sung, Seong-Min Choi, Jonghwa Kim, Jun Young Ha, Byeong-Chae Kim, Hwan Heo, Sang Woo Park
Scientific Reports.2019;[Epub] CrossRef
Probiotics for Parkinson’s Disease
Gazerani
International Journal of Molecular Sciences.2019; 20(17): 4121. CrossRef
The Role of the Gut Microbiota in the Pathogenesis of Parkinson's Disease
Dongming Yang, Deming Zhao, Syed Zahid Ali Shah, Wei Wu, Mengyu Lai, Xixi Zhang, Jie Li, Zhiling Guan, Huafen Zhao, Wen Li, Hongli Gao, Xiangmei Zhou, Lifeng Yang
Frontiers in Neurology.2019;[Epub] CrossRef
Long-Term Voluntary Physical Exercise Exerts Neuroprotective Effects and Motor Disturbance Alleviation in a Rat Model of Parkinson’s Disease
Wan-Ling Tsai, Hsin-Yung Chen, Ying-Zu Huang, Yuan-Hao Chen, Chi-Wei Kuo, Kai-Yun Chen, Tsung-Hsun Hsieh
Behavioural Neurology.2019; 2019: 1. CrossRef
The effectiveness of istradefylline for the treatment of gait deficits and sleepiness in patients with Parkinson’s disease
Keita Matsuura, Hiroyuki Kajikawa, Ken-ichi Tabei, Masayuki Satoh, Hirotaka Kida, Naoko Nakamura, Hidekazu Tomimoto
Neuroscience Letters.2018; 662: 158. CrossRef
Predictors of Mortality in Nondemented Patients With Parkinson Disease: Motor Symptoms Versus Nonmotor Symptoms
D. Santos-García, E. Suárez-Castro, J. Ernandez, I. Expósito-Ruiz, C. Tuñas-Gesto, M. Aneiros-Díaz, T. de Deus-Fonticoba, M. López-Fernández, D. Núñez-Arias
Journal of Geriatric Psychiatry and Neurology.2018; 31(1): 19. CrossRef
Additive Effects of Levodopa and a Neurorestorative Diet in a Mouse Model of Parkinson’s Disease
Paula Perez-Pardo, Laus M. Broersen, Tessa Kliest, Nick van Wijk, Amos Attali, Johan Garssen, Aletta D. Kraneveld
Frontiers in Aging Neuroscience.2018;[Epub] CrossRef
Ghrelin and Neurodegenerative Disorders—a Review
Limin Shi, Xixun Du, Hong Jiang, Junxia Xie
Molecular Neurobiology.2017; 54(2): 1144. CrossRef
The neurological effects of ghrelin in brain diseases: Beyond metabolic functions
Qian Jiao, Xixun Du, Yong Li, Bing Gong, Limin Shi, Tingting Tang, Hong Jiang
Neuroscience & Biobehavioral Reviews.2017; 73: 98. CrossRef
First-in-human assessment of PRX002, an anti-α-synuclein monoclonal antibody, in healthy volunteers
Dale B. Schenk, Martin Koller, Daniel K. Ness, Sue G. Griffith, Michael Grundman, Wagner Zago, Jay Soto, George Atiee, Susanne Ostrowitzki, Gene G. Kinney
Movement Disorders.2017; 32(2): 211. CrossRef
Normal ‘heart’ in Parkinson's disease: is this a distinct clinical phenotype?
J.‐S. Kim, H.‐E. Park, I.‐S. Park, Y.‐S. Oh, D.‐W. Ryu, I.‐U. Song, Y.‐A. Jung, I. R. Yoo, H.‐S. Choi, P. H. Lee, K.‐S. Lee
European Journal of Neurology.2017; 24(2): 349. CrossRef
α-Synuclein in the colon and premotor markers of Parkinson disease in neurologically normal subjects
Joong-Seok Kim, In-Seok Park, Hyung-Eun Park, Su-Young Kim, Jung A Yun, Chan Kwon Jung, Hye-Young Sung, Jin-Kwon Lee, Won-Kyung Kang
Neurological Sciences.2017; 38(1): 171. CrossRef
Use of monoamine oxidase inhibitors in chronic neurodegeneration
Peter Riederer, Thomas Müller
Expert Opinion on Drug Metabolism & Toxicology.2017; 13(2): 233. CrossRef
Validation of the Korean Version of the Scale for Outcomes in Parkinson’s Disease-Autonomic
Ji-Young Kim, In-Uk Song, Seong-Beom Koh, Tae-Beom Ahn, Sang Jin Kim, Sang-Myung Cheon, Jin Whan Cho, Yun Joong Kim, Hyeo-Il Ma, Mee-Young Park, Jong Sam Baik, Phil Hyu Lee, Sun Ju Chung, Jong-Min Kim, Han-Joon Kim, Young-Hee Sung, Do Young Kwon, Jae-Hyeo
Journal of Movement Disorders.2017; 10(1): 29. CrossRef
Retinal biomarkers provide “insight” into cortical pharmacology and disease
Christine T.O. Nguyen, Flora Hui, Jason Charng, Shajan Velaedan, Anna K. van Koeverden, Jeremiah K.H. Lim, Zheng He, Vickie H.Y. Wong, Algis J. Vingrys, Bang V. Bui, Magnus Ivarsson
Pharmacology & Therapeutics.2017; 175: 151. CrossRef
Promising Effects of Neurorestorative Diets on Motor, Cognitive, and Gastrointestinal Dysfunction after Symptom Development in a Mouse Model of Parkinson's Disease
Paula Perez-Pardo, Esther M. de Jong, Laus M. Broersen, Nick van Wijk, Amos Attali, Johan Garssen, Aletta D. Kraneveld
Frontiers in Aging Neuroscience.2017;[Epub] CrossRef
DaT-SPECT assessment depicts dopamine depletion among asymptomatic G2019S LRRK2 mutation carriers
Moran Artzi, Einat Even-Sapir, Hedva Lerman Shacham, Avner Thaler, Avi Orr Urterger, Susan Bressman, Karen Marder, Talma Hendler, Nir Giladi, Dafna Ben Bashat, Anat Mirelman, Elisa Greggio
PLOS ONE.2017; 12(4): e0175424. CrossRef
The gut-brain axis in Parkinson's disease: Possibilities for food-based therapies
Paula Perez-Pardo, Tessa Kliest, Hemraj B. Dodiya, Laus M. Broersen, Johan Garssen, Ali Keshavarzian, Aletta D. Kraneveld
European Journal of Pharmacology.2017; 817: 86. CrossRef
Who Can Diagnose Parkinson's Disease First? Role of Pre-motor Symptoms
Mayela Rodríguez-Violante, Rosalía Zerón-Martínez, Amin Cervantes-Arriaga, Teresa Corona
Archives of Medical Research.2017; 48(3): 221. CrossRef
Microbes Tickling Your Tummy: the Importance of the Gut-Brain Axis in Parkinson’s Disease
Paula Perez-Pardo, Mitch Hartog, Johan Garssen, Aletta D. Kraneveld
Current Behavioral Neuroscience Reports.2017; 4(4): 361. CrossRef
The Therapeutic Potential of Exercise to Improve Mood, Cognition, and Sleep in Parkinson's Disease
Gretchen O. Reynolds, Michael W. Otto, Terry D. Ellis, Alice Cronin‐Golomb
Movement Disorders.2016; 31(1): 23. CrossRef
Orthostatic hypotension and cardiac sympathetic denervation in Parkinson disease patients with REM sleep behavioral disorder
Joong-Seok Kim, Hyung-Eun Park, Yoon-Sang Oh, Si-Hoon Lee, Jeong-Wook Park, Byung-chul Son, Kwang-Soo Lee
Journal of the Neurological Sciences.2016; 362: 59. CrossRef
Relearning of Writing Skills in Parkinson's Disease After Intensive Amplitude Training
Evelien Nackaerts, Elke Heremans, Griet Vervoort, Bouwien C.M. Smits‐Engelsman, Stephan P. Swinnen, Wim Vandenberghe, Bruno Bergmans, Alice Nieuwboer
Movement Disorders.2016; 31(8): 1209. CrossRef
Cardiovascular Autonomic Dysfunction in Mild and Advanced Parkinson’s Disease
Joong-Seok Kim, Si-Hoon Lee, Yoon-Sang Oh, Jeong-Wook Park, Jae-Young An, Sung-Kyung Park, Si-Ryung Han, Kwang-Soo Lee
Journal of Movement Disorders.2016; 9(2): 97. CrossRef
The KMDS-NATION Study: Korean Movement Disorders Society Multicenter Assessment of Non-Motor Symptoms and Quality of Life in Parkinson's Disease NATION Study Group
Do-Young Kwon, Seong-Beom Koh, Jae Hyeok Lee, Hee Kyung Park, Han-Joon Kim, Hae-Won Shin, Jinyoung Youn, Kun Woo Park, Sun-Ah Choi, Sang Jin Kim, Seong-Min Choi, Ji-Yun Park, Beom S. Jeon, Ji Young Kim, Sun Ju Chung, Chong Sik Lee, Jeong-Ho Park, Tae-Beom
Journal of Clinical Neurology.2016; 12(4): 393. CrossRef
Bent out of shape: α‐Synuclein misfolding and the convergence of pathogenic pathways in Parkinson's disease
Esteban Luna, Kelvin C. Luk
FEBS Letters.2015; 589(24PartA): 3749. CrossRef
Differentiated Cells Derived from Fetal Neural Stem Cells Improve Motor Deficits in a Rat Model of Parkinson's Disease
Wei Wang, Hao Song, Aifang Shen, Chao Chen, Yanming Liu, Yabing Dong, Fabin Han
Translational Neuroscience and Clinics.2015; 1(2): 75. CrossRef

First
Prev
Page of 1
Next
Last

Search